Boston Scientific Corporation (NYSE:BSX) has announced the signing of a definitive agreement with European specialty pharmaceutical group, SERB’s affiliates SERB SAS and Stark International Lux S.A.R.L. The agreement is for the sale of Boston Scientific’s...
